51
Views
10
CrossRef citations to date
0
Altmetric
Review

Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection

&
Pages 331-340 | Published online: 30 Apr 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Stefania Ferro, Laura De Luca, Francesca Morreale, Frauke Christ, Zeger Debyser, Rosaria Gitto & Alba Chimirri. (2014) Synthesis and biological evaluation of novel antiviral agents as protein–protein interaction inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 29:2, pages 237-242.
Read now
Christine Katlama & Robert Murphy. (2012) Dolutegravir for the treatment of HIV. Expert Opinion on Investigational Drugs 21:4, pages 523-530.
Read now
Todd Wills & Vivian Vega. (2012) Elvitegravir: a once-daily inhibitor of HIV-1 integrase. Expert Opinion on Investigational Drugs 21:3, pages 395-401.
Read now

Articles from other publishers (7)

Rauf Bhat, Sameh S.M. Soliman, Magdy M El-Sayed Ahmed & Mohamed I. Husseiny. (2021) COVID-19 Pandemic: Outbreak, Potential Vaccines And Medications. Russian Open Medical Journal 10:4.
Crossref
Nicole L. De La Mata, David A. Cooper, Darren Russell, Don Smith, Ian Woolley, Maree O. Sullivan, Stephen Wright & Matthew Law. (2016) Treatment durability and virological response in treatment-experienced HIV-positive patients on an integrase inhibitor-based regimen: an Australian cohort study. Sexual Health 13:4, pages 335.
Crossref
Erik De Clercq. (2012) Tenofovir: Quo Vadis Anno 2012 (Where Is It Going in the Year 2012) ? . Medicinal Research Reviews 32:4, pages 765-785.
Crossref
Erina Pretorius, Hartwig Klinker & Bernd Rosenkranz. (2011) The Role of Therapeutic Drug Monitoring in the Management of Patients With Human Immunodeficiency Virus Infection. Therapeutic Drug Monitoring 33:3, pages 265-274.
Crossref
Jean-François Mouscadet & Didier Desmaële. (2010) Chemistry and Structure-Activity Relationship of the Styrylquinoline-Type HIV Integrase Inhibitors. Molecules 15:5, pages 3048-3078.
Crossref
Nathan Ford & Alexandra Calmy. (2010) Improving first-line antiretroviral therapy in resource-limited settings. Current Opinion in HIV and AIDS 5:1, pages 38-47.
Crossref
Liã Bárbara ArrudaLuiz Augusto M. FonsecaAlberto J.S. DuarteJorge Casseb. (2010) Genetic Diversity on the Integrase Region of the pol Gene among HIV Type 1-Infected Patients Naive for Integrase Inhibitors in São Paulo City, Brazil . AIDS Research and Human Retroviruses 26:1, pages 105-107.
Crossref